Source: Eur Respir J, 58 (6) 2101416; 10.1183/13993003.01416-2021



Rating:

Share or cite this content

Citations should be made in the following way:
James D. Chalmers, Holly R. Keir. Less is more? Antibiotic treatment duration for exacerbations of bronchiectasis. Eur Respir J, 58 (6) 2101416; 10.1183/13993003.01416-2021

Member's Comments

No comment yet.

Related content which might interest you: Acute exacerbation of bronchiectasis and the impact on the duration of antibiotic therapy Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019 Antibiotic choice and repeat prescriptions in infective COPD exacerbations Source: International Congress 2019 – Exacerbations of airway diseases Year: 2019 Is antibiotic treatment during asthma exacerbation necessary ? Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017 Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD? Source: Eur Respir J, 54 (4) 1901405; 10.1183/13993003.01405-2019 Year: 2019 Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD? Source: Eur Respir J, 54 (4) 1901597; 10.1183/13993003.01597-2019 Year: 2019 Does having previous sputum results improve rationalisation of antimicrobial prescribing during acute exacerbations of COPD? Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 Antibiotic prescribing in patients with acute bronchitis Source: Annual Congress 2007 - Primary care respiratory problems Year: 2007 Impact of bronchiectasis on duration of hospitalization in patients with exacerbations of COPD Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015 Treatment to prevent exacerbations in bronchiectasis: macrolides as first line? Source: Eur Respir J, 54 (1) 1901213; 10.1183/13993003.01213-2019 Year: 2019 Does sputum, biochemical and radiological markers of infection correlate with antibiotic prescribing in acute exacerbations of COPD? Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 Antibiotic treatment and prevention of exacerbations of COPD Source: Eur Respir Monogr 2013; 60: 96-106 Year: 2013 Duration of systemic corticosteroids treatment in COPD exacerbations Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008 COPD: antibiotic strategy in infectious exacerbations Source: Eur Respir J 2001; 18: Suppl. 33, 137s Year: 2001 Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations? Source: Breathe, 15 (4) 353; 10.1183/20734735.0257-2019 Year: 2019 What is the role of prophylactic antibiotic therapy in chronic bronchitis or COPD? Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new? Year: 2009 Antibiotic treatment and prophylaxis Source: Annual Congress 2006 - Infections and chronic obstructive lung diseases Year: 2006 Antibiotic treatment strategies in adults with bronchiectasis Source: Eur Respir Mon 2011; 52: 211-222 Year: 2011 Long-term azithromycin therapy in severe COPD with repeated exacerbations Source: Annual Congress 2010 - COPD exacerbation Year: 2010 Sputum purulence guided antibiotic therapy in patients with exacerbations of COPD requiring hospitalization Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008